Open AccessThis article is
- freely available
Inflammation Amplification by Versican: The First Mediator
Department of Biochemistry and Molecular Biology, Second Military Medical University, Shanghai 200433, China
Department of Pharmacology, Zhejiang Chinese Medical University, Hangzhou 310053, China
These authors contributed equally to this work.
* Author to whom correspondence should be addressed.
Received: 20 April 2012; in revised form: 3 May 2012 / Accepted: 29 May 2012 / Published: 6 June 2012
Abstract: The effects of inflammation may not always benefit the individual. Its amplifying nature represents a highly regulated biological program, and the inflammatory microenvironment is its essential component. Growing evidence suggests that the ECM (extracellular matrix) is important for the early steps of inflammation. Versican, a ubiquitous component of the ECM, contributes to the formation of the inflammatory response and is highly regulated by cytokines. Certain cytokines exert their initial effects on versican to alter the homeostasis of the inflammatory milieu, and inappropriate production of versican may promote the next inflammatory response. Therefore, versican could be the first step in the amplification of the inflammatory response, and ongoing research of this molecule may help to explain the pathogenesis of inflammation.
Keywords: versican; cytokines; extracellular matrix homeostasis; inflammation amplification
Article StatisticsClick here to load and display the download statistics.
Notes: Multiple requests from the same IP address are counted as one view.
Cite This Article
MDPI and ACS Style
Zhang, Z.; Miao, L.; Wang, L. Inflammation Amplification by Versican: The First Mediator. Int. J. Mol. Sci. 2012, 13, 6873-6882.
Zhang Z, Miao L, Wang L. Inflammation Amplification by Versican: The First Mediator. International Journal of Molecular Sciences. 2012; 13(6):6873-6882.
Zhang, Zhenwei; Miao, Lei; Wang, Lianghua. 2012. "Inflammation Amplification by Versican: The First Mediator." Int. J. Mol. Sci. 13, no. 6: 6873-6882.